Advanced search
Publication Cover
International Journal of Radiation Biology Volume 75, 1999 - Issue 11
Submit an article Journal homepage
173
Views
98
CrossRef citations to date
0
Altmetric
Research Article

Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours

E. K. Rofstad, K. Maseide
Pages 1377-1393 | Published online: 03 Jul 2009

  • ADAMS, G. E., HASAN, N.M. and JOINER, M. C., 1997, Radiation, hypoxia and genetic stimulation: implications for future therapies. Radiotherapy and Oncology, 44, 101-109.
  • ARTEEL, G. E., THURMAN, R. G., YATES, J. M. and RALEIGH, J. A., 1995, Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion in rat livers. British Journal of Cancer, 72, 889-895.
  • AZUMA, C., RALEIGH, J. A. and THRALL, D. E., 1997, Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime. Radiation Research, 148, 35-42.
  • BRIZEL, D. M., SCULLY, S. P., HARRELSON, J. M., LAYFIELD, L. J., BEAN, J. M., PROSNITZ, L. R. and DEWHIRST, M. W., 1996, Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Research, 56, 941-943.
  • BRIZEL, D. M., SIBLEY, G. S., PROSNITZ, L. R., SCHER, R. L. and DEWHIRST, M. W., 1997, Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. International Journal of Radiation Oncology, Biology, Physics, 38, 285-289.
  • CHAPLIN, D. J. and HORSMAN, M. R., 1992, Tumor blood flow changes induced by chemical modifiers of radiation response. International Journal of Radiation Oncology, Biology, Physics, 22, 459-462.
  • CHAPMAN, J. D., LEE, J. and MEEKER, B. E., 1989, Keynote address: cellular reduction of nitroimidazole drugs: potential for selective chemotherapy and diagnosis of hypoxic cells. International Journal of Radiation Oncology, Biology, Physics, 16,911-917.
  • CLINE, J. M., THRALL, D. E., PAGE, R. L., FRANKO, A. J. and RALEIGH, J. A., 1990, Immuno-histochemical detection of a hypoxia marker in spontaneous canine tumours. British Journal of Cancer, 62, 925-931.
  • CLINE, J. M., THRALL, D. E., ROSNER, G. L. and RALEIGH, J. A., 1994, Distribution of the hypoxia marker CC1-103F in canine tumors. International Journal of Radiation Oncology, Biology, Physics, 28, 921-933.
  • COLEMAN, C. N., 1988, Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity. Journal of the National Cancer Institute, 80, 310-317.
  • DANIELSEN, T. and ROFSTAD, E. K., 1998, VEGF, bFGF and EGF in the angiogenesis of human melanoma xenografts. International Journal of Cancer, 76, 836-841.
  • DEGNER, F. L. and SUTHERLAND, R. M., 1988, Mathematical modelling of oxygen supply and oxygenation in tumor tissues: prognostic, therapeutic, and experimental implica- dons. International Journal of Radiation Oncology, Biology, Physics, 15, 391-397.
  • DENEKAMP, J., DASU, A., WAITES, A. and LITTBRAND, B., 1998, Hyperfractionation as an effective way of overcoming radioresistance. International Journal of Radiation Oncology, Biology, Physics, 42, 705-709.
  • DEWHIRST, M. W., KIMURA, H., REHMUS, S. W. E., BRAUN, R. D., PAPAHADIOPOULOS, D., HONG, K. and SECOMB, T. W., 1996, Microvascular studies on the origins of perfusion-limited hypoxia. British Journal of Cancer, 74 (suppl. XXVII), s247-251.
  • DURAND, R. E. and LEPARD, N. E., 1995, Contribution of transient blood flow to tumour hypoxia in mice. Acta Oncologica, 34, 317-323.
  • DURAND, R. E. and RALEIGH, J. A., 1998, Identification of nonproliferating but viable hypoxic tumor cells in vivo. Cancer Research, 58, 3547-3550.
  • EVANS, S. M., JENKINS, W. T., JOINER, B., LORD, E. M. and KOCH, C. J., 1996, 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. Cancer Research, 56, 405-411.
  • EVANS, S. M., JOINER, B., JENKINS, W. T., LAUGHLIN, K. M., LORD, E. M. and KOCH, C. J., 1995, Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-lH-imidazol-l-yl)N-(2,2,3,3,3-pentafluoropropyl)acetamide]. British Journal of Cancer, 72, 875-882.
  • FENTON, B. M., KIANI, M. F. and SIEMANN, D. W., 1995, Should direct measurements of tumor oxygenation relate to the radiobiological hypoxic fraction of a tumor? International Journal of Radiation Oncology, Biology, Physics, 33, 365-373.
  • FRANKO, A. J., KOCH, C. J. and BOISVERT, D. P. J., 1992, Distribution of misonidazole adducts in 9L gliosarcoma tumors and spheroids: implications for oxygen distribution. Cancer Research, 52, 3831-3837.
  • GILLESPIE, C. J., CHAPMAN, J. D., REUVERS, A. P. and DUGLE D. L., 1975, The inactivation of Chinese hamster cells by X rays: synchronized and exponential cell populations. Radiation Research, 64, 353-364.
  • GROEBE, K. and VAUPEL, P., 1988, Evaluation of oxygen diffusion distances in human breast cancer xenografts using tumorspecific in moo data: role of various mechanisms in the development of tumor hypoxia. International Journal of Radiation Oncology, Biology, Physics, 15, 691-697.
  • HILL, R. P., 1990, Tumor progression: potential role of unstable genomic changes. Cancer Metastasis Reviews, 9, 137-147.
  • HODGKISS, R. J., JONES, G., LONG, A., PARRICK, J., SMITH, K. A., STRATFORD, M. R. L. and WILSON, G. D., 1991, Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. British Journal of Cancer, 63, 119-125.
  • HORSMAN, M. R., 1995, Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. Acta Oncologica, 34, 571-587.
  • HOCKEL, M., KNOOP, C., SCHLENGER, K., VORNDRAN, B., BAUSSMANN, E., MITZE, M., KNAPSTEIN, P. G. and VAUPEL, P., 1993, Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiotherapy and Oncology, 26, 45-50.
  • HOCKEL, M., SCHLENGER, K., ARAL, B., MITZE, M., SCHAFFER, U. and VAUPEL, P., 1996, Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Research, 56, 4509-4515.
  • KAVANAGH, M.-C., SUN, A., HU, Q. and HILL, R. P., 1996, Comparing techniques of measuring tumor hypoxia in different murine tumors: Eppendorf pO2 histograph, [3H]misonidazole binding and paired survival assay. Radiation Research, 145, 491-500.
  • KENNEDY, A. S., RALEIGH, J. A., PEREZ, G. M., CALKINS, D. P., THRALL, D. E., NOVOTNY, D. B. and VARIA, M. A., 1997, Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. International Journal of Radiation Oncology, Biology, Physics, 37, 897-905.
  • KIM, I. H., LEMMON, M. J. and BROWN, J. M., 1993, The influence of irradiation of the tumor bed on tumor hypoxia: measurements by radiation response, oxygen electrodes, and nitro-imidazole binding. Radiation Research, 135,411-417.
  • KIMURA, H., BRAUN, R. D., ONG, E. T., H su, R., SECOMB, T. W., PAPAHADIOPOULOS, D., HONG, K. and DEWHIRST, M. W., 1996, Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Research, 56, 5522-5528.
  • LEE, J., SIEMANN, D. W., KOCH, C. J. and LORD, E. M., 1996, Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts. International Journal of Cancer, 67, 372-378.
  • LORD, E. M., HARWELL, L. and KOCH, C. J., 1993, Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Research, 53, 5721-5726.
  • MOULDER, J. E. and ROCKWELL, S., 1984, Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. International Journal of Radiation Oncology, Biology, Physics, 10, 695-712.
  • MUELLER-KLIESER, W., SCHLENGER, K.-H., WALENTA, S., GROSS, M., KARBACH, U., HOECKEL, M. and VAUPEL, P., 1991, Pathophysiological approaches to identifying tumor hypoxia in patients. Radiotherapy and Oncology, Suppl. 20, 21-28.
  • NORDSMARK, M., OVERGAARD, M. and OVERGAARD, J., 1996, Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiotherapy and Oncology, 41, 31-39.
  • OVERGAARD, J., 1989, Sensitization of hypoxic tumour cells clinical experience. International Journal of Radiation Biology, 56,801-811.
  • O VERGAARD, J. and H ORSMAN, M. R., 1993, Overcoming hypoxic cell radioresistance. In G. G. Steel (ed.), Basic Clinical Radiobiology for Radiation Oncologists (London: Edward Arnold), pp. 163-172.
  • RALEIGH, J. A., CALKINS-ADAMS, D. P., RINKER, L. H., BALLENGER, C. A., WEISSLER, M. C., FOWLER, W. C., NOVOTNY, D. B. and VARIA, M. A., 1998a, Hypoxia and vascular endothelial growth factor protein expression in human tumors. Cancer Research, 58, 3765-3768.
  • RALEIGH, J. A., CHOU, S. C., TABLES, L., SUCHINDRAN, S., VARIA, M. A. and HORSMAN, M. R., 1998b, Relationship of hypoxia to metallothionein expression in murine tumors. International Journal of Radiation Oncology, Biology, Physics, 42, 727-730.
  • RALEIGH, J. A., DEWHIRST, M. W. and THRALL, D. E., 1996, Measuring tumor hypoxia. Seminars in Radiation Oncology, 6, 37-45.
  • RALEIGH, J. A., MILLER, G. G., FRANKO, A. J., KOCH, C. J., FUCIARELLI, A. F. and KELLY, D. A., 1987, Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. British Journal of Cancer, 56, 395-400.
  • RASEY, J. S., KOH, W., GRIERSON, J. R., GRUNBAUM, Z. and KROHN, K. A., 1989, Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia. International Journal of Radiation Oncology, Biology, Physics, 17, 985-991.
  • REYNOLDS, T. Y., ROCKWELL, S. and GLAZER, P. M., 1996, Genetic instability induced by the tumor microenvironment. Cancer Research, 56, 5754-5757.
  • ROCKWELL, S. and MOULDER, J. E., 1990, Hypoxie fractions of human tumors xenografted into mice: a review. International Journal of Radiation Oncology, Biology, Physics, 19, 197-202.
  • ROFSTAD, E. K., 1994, Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. British Journal of Cancer, 70, 804-812.
  • ROFSTAD, E. K. and DANIELSEN, T., 1998, Hypoxia-induced angiogenesis and vascular endothelial growth factor secretion in human melanoma. British Journal of Cancer, 77, 897-902.
  • ROFSTAD, E. K. and DANIELSEN, T., 1999, Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis. British Journal of Cancer, 80, 1697-1707.
  • SANNA, K. and ROFSTAD, E. K., 1994, Hypoxia-induced resistance to doxorubicin and methotrexate in human melanoma cells in vitro. International Journal of Cancer, 58,258-262.
  • SMITHEN, C. E. and HARDY, C. R., 1982, The chemistry of nitroimidazole hypoxic cell radio-sensitizers. In A. Breccia, C. Rimondi and G. E. Adams (eds), Advanced Topics on Radiosensitizers of Hypoxic Cells (New York: Plenum), pp. 1-47.
  • STONE, H. B., BROWN, J. M., PHILLIPS, T. L. and SUTHERLAND, R. M., 1993, Oxygen in human tumors: correlations between methods of measurement and response to therapy. Radiation Research, 136, 422-434.
  • SUNDF0R, K., LYNG, H. and ROFSTAD, E. K., 1998, Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. British Journal of Cancer, 78, 822-827.
  • SUTHERLAND, R. M., AUSSERER, W. A., MURPHY, B. J. and LADEROUTE, K. R., 1996, Tumor hypoxia and heterogeneity: challenges and opportunities for the future. Seminars in Radiation Oncology, 6, 59-70.
  • TANNOCK, I. F., 1972, Oxygen diffusion and the distribution of cellular radiosensitivity in tumors. British Journal of Radiology, 45, 515-524.
  • TEICHER, B. A., 1994, Hypoxia and drug resistance. Cancer Metastasis Reviews, 13, 139-168.
  • TROTTER, M. J., CHAPLIN, D. J., DURAND, R. E. and OLIVE, P. L., 1989, The use of fluorescent probes to identify regions of transient perfusion in murine tumors. International Journal of Radiation Oncology, Biology, Physics, 16, 931-934.
  • TROTTER, M. J., CHAPLIN, D. J. and OLIVE, P. L., 1991, Possible mechanisms for intermittent blood flow in the murine SCCVII carcinoma. International Journal of Radiation Biology, 60, 139-146.
  • TUFTO, I., LYNG, H. and ROFSTAD, E. K., 1998, Vascular density in human melanoma xenografts: relationship to angiogenesis, perfusion and necrosis. Cancer Letters, 123, 159-165.
  • TUFTO, I. and ROFSTAD, E. K., 1995, Transient perfusion in human melanoma xenografts. British Journal of Cancer, 71, 789-793.
  • URTASUN, R. C., CHAPMAN, J. D., RALEIGH, J. A., FRANKO, A. J. and KOCH, C. J., 1986, Binding of H-misonidazole to solid human tumors as a measure of tumor hypoxia. International Journal of Radiation Oncology, Biology, Physics, 12, 1263-1267.
  • VARIA, M. A., CALKINS-ADAMS, D. P., RINKER, L. H., KENNEDY, A. S., NOVOTNY, D. B, FOWLER, W. C. and RALEIGH, J. A., 1998, A novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecologic Oncology, 71, 270-277.
  • VAUPEL, P., 1990, Oxygenation of human tumors. Strahlentherapie und Onkologie, 166, 377-386.
  • WEIBEL, E. R., 1979, Stereological Methods (London: Academic).
  • WOODS, M. L., KOCH, C. J. and LORD, E. M., 1996, Detection of individual hypoxic cells in multicellular spheroids by flow cytometry using the 2-nitroimidazole, EF5, and monoclonal antibodies. International Journal of Radiation Oncology, Biology, Physics, 34, 93-101.
  • WOUTERS, B. G. and BROWN, J. M., 1997, Cells at intermediate oxygen levels can be more important than the 'hypoxic fraction' in determining tumor response to fractionated radiotherapy. Radiation Research, 147, 541-550.
  • YOUNG, S.D., MARSHALL, R. S. and HILL, R. P., 1988, Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proceedings of the National Academy of Sciences, USA, 85, 9533-9537.
  • ZEMAN, E. M., CALKINS, D. P., CLINE, J. M., THRALL, D. E. and RALEIGH, J. A., 1993, The relationship between proliferative and oxygenation status in spontaneous canine tumors. International Journal of Radiation Oncology, Biology, Physics, 27, 891-898.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.